Cargando...
Non-factor replacement therapy for haemophilia: a current update
One of the most challenging issues facing us in the treatment of haemophilia is the development of alloantibodies against infused factor VIII (FVIII) or factor IX (FIX). Inhibitors render factor replacement therapy ineffective, exposing patients to an unacceptably high risk of morbidity and mortalit...
Guardado en:
| Publicado en: | Blood Transfus |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Edizioni SIMTI - SIMTI Servizi Srl
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125230/ https://ncbi.nlm.nih.gov/pubmed/29517971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2018.0272-17 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|